Transcriptomic and proteomic insights into progressive myoclonus epilepsy type 1

Disease Models & Mechanisms · Published 2026-03-05 · DOI 10.1242/dmm.052681

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1242/dmm.052681

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Nestin/CXCL12 immunohistochemistry and RNA sequencing map the bone marrow microenvironment in aplastic anemia · Disease Models & Mechanisms · 2026 · Same journal
• Spinning leukaemic cells to study their drug resistance · Disease Models & Mechanisms · 2026 · Same journal
• An antioxidant therapy elicits distinct transcriptome responses in 22q11-deleted upper layer cortical projection neurons · Disease Models & Mechanisms · 2026 · Same journal
• Hyperpolarised magnetic resonance spectroscopy with lab-on-a-chip disease models · Disease Models & Mechanisms · 2026 · Same journal
• Folate and magnesium rescue developmental toxicity of HIV drug · Disease Models & Mechanisms · 2026 · Same journal
• Clarifying Frizzled 2 function in development through genetically validated mouse models · Disease Models & Mechanisms · 2026 · Same journal
• Gut-derived Unpaired-3 cytokine signaling promotes systemic hypoxia tolerance in Drosophila · Disease Models & Mechanisms · 2026 · Same journal
• Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology · Disease Models & Mechanisms · 2026 · Same journal
• Inflammatory responses following CRISPR modification of the nuclear localisation sequence in endogenous interleukin-1 alpha · Disease Models & Mechanisms · 2026 · Same journal
• Why in vivo models of disease remain indispensable · Disease Models & Mechanisms · 2026 · Same journal